Business Description
Bausch Health Companies Inc
NAICS : 325410
SIC : 3741
ISIN : CA0717341071
Total Employee Number:
20,300Compare
Compare
Traded in other countries / regions
BHC.CanadaBHC.USABHCN.MexicoBVF.Germany0QYW.UK Index Membership
S&P/TSX Composite index IPO Date
1987-06-29Description
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -0.08 | |||||
Debt-to-Equity | -10.1 | |||||
Debt-to-EBITDA | 10.71 | |||||
Interest Coverage | 1.46 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.01 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 4.5 | |||||
3-Year Book Growth Rate | 7.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.15 | |||||
9-Day RSI | 43.22 | |||||
14-Day RSI | 43.35 | |||||
3-1 Month Momentum % | 5.37 | |||||
6-1 Month Momentum % | -24.19 | |||||
12-1 Month Momentum % | -14.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 195.45 | |||||
Days Sales Outstanding | 78.55 | |||||
Days Payable | 73.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 43.3 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.04 | |||||
Operating Margin % | 23.21 | |||||
Net Margin % | -11.44 | |||||
EBITDA Margin % | 18.4 | |||||
FCF Margin % | 9.41 | |||||
OCF Margin % | 13.49 | |||||
ROA % | -4.54 | |||||
ROIC % | 10.87 | |||||
3-Year ROIIC % | 181.7 | |||||
ROC (Joel Greenblatt) % | 26.09 | |||||
ROCE % | 3.37 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 1.2 | |||||
PE Ratio without NRI | 2.54 | |||||
PEG Ratio | 0.33 | |||||
PS Ratio | 0.18 | |||||
Price-to-Free-Cash-Flow | 1.87 | |||||
Price-to-Operating-Cash-Flow | 1.3 | |||||
EV-to-EBIT | 31.02 | |||||
EV-to-Forward-EBIT | 12.4 | |||||
EV-to-EBITDA | 11.84 | |||||
EV-to-Forward-EBITDA | 6.23 | |||||
EV-to-Revenue | 2.18 | |||||
EV-to-Forward-Revenue | 2 | |||||
EV-to-FCF | 23.16 | |||||
Price-to-GF-Value | 0.61 | |||||
Price-to-Projected-FCF | 0.47 | |||||
Price-to-Median-PS-Value | 0.29 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.27 | |||||
Earnings Yield (Greenblatt) % | 3.22 | |||||
FCF Yield % | 53.89 | |||||
Forward Rate of Return (Yacktman) % | 44.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Ā
Total Annual Return % Ā
Bausch Health Companies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 14,486.909 | ||
| EPS (TTM) (C$) | -4.444 | ||
| Beta | 0.943 | ||
| 3-Year Sharpe Ratio | -0.05 | ||
| 3-Year Sortino Ratio | -0.09 | ||
| Volatility % | 62.16 | ||
| 14-Day RSI | 43.35 | ||
| 14-Day ATR (C$) | 0.398094 | ||
| 20-Day SMA (C$) | 7.031 | ||
| 12-1 Month Momentum % | -14.65 | ||
| 52-Week Range (C$) | 6.45 - 11.97 | ||
| Shares Outstanding (Mil) | 373.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bausch Health Companies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bausch Health Companies Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 17:00 | In 124 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 123 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 17:00 | In 33 days | ||
| Second quarter earnings results for 2026 | 2026-07-30 | In 32 days | ||
| Guidance call for 2026 | 2026-05-20 09:30 | 7.33 (-1.35%) | ||
| Barclays 30th Annual Leveraged Finance Conference | 2026-05-19 10:25 | 7.47 (-0.13%) | ||
| General meeting for 2026 | 2026-05-19 09:00 | 7.47 (-0.13%) | ||
| First quarter earnings conference call for 2026 | 2026-04-29 17:00 | 7.77 (+1.83%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 7.77 (+1.83%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-18 17:00 | 8.17 (-0.97%) |
Show
Entries
Bausch Health Companies Inc Frequently Asked Questions
What is Bausch Health Companies Inc(TSX:BHC)'s stock price today?
The current price of TSX:BHC is C$6.77. The 52 week high of TSX:BHC is C$11.97 and 52 week low is C$6.45.
When is next earnings date of Bausch Health Companies Inc(TSX:BHC)?
The next earnings date of Bausch Health Companies Inc(TSX:BHC) is 2026-07-30 Est..
Does Bausch Health Companies Inc(TSX:BHC) pay dividends? If so, how much?
Bausch Health Companies Inc(TSX:BHC) does not pay dividend.
Press Release
Articles on Bausch Health Companies Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers